Benzinga | Nov 19, 2021 11:37AM EST

Acorda Therapeutics Shares Quiet, See Large Spike In Volume; FDA AccessData.gov Listing For Co.'s New Drug Application For Dalfampridine Shows FDA Approved

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022250